Objectives: To analyze selective COX 2 inhibitor nonsteroidal anti-inflammatory drugs (NSAID) in terms of their mechanism of action, principal indications, posology and most common adverse effects.
Introduction
Nonsteroidal anti-inflammatory drugs (NSAID) comprise a heterogeneous group of medications, the majority of which are organic acids with analgesic, antipyretic and anti-inflammatory actions. These drugs are widely used to control fever and acute or chronic pain. 1 They are the most sold medications worldwide and, together with analgesics and antipyretics, account for approximately 30% of all medicines used (prescribed by physicians or otherwise). 1 
Synthesis of prostaglandins and leukotrienes
When there is damage to the cell membrane, which is basically made up of phospholipids, the enzyme phospholipase A2, which is present in leukocytes and platelets, is activated by proinflammatory cytokines, such as interleukin (IL)-1. This enzyme leads to the degradation of phospholipids, resulting in production of arachidonic acid . This, when metabolized, forms leukotrienes through the action of the enzyme lipoxygenase, and prostaglandins, prostacyclins and thromboxanes, through the action of the cyclooxygenase enzyme (COX).
COX is the first enzyme involved in producing prostaglandins from arachidonic acid. [2] [3] [4] It converts, by oxygenation, the arachidonic acid into two unstable components: prostaglandin G2 and prostaglandin H2.
These prostaglandins are later transformed by isomerases into prostacyclin, thromboxane A2, and prostaglandins D2, E2 and F2α. Prostaglandin E2 is important because of its pyrogenic action and in increasing sensitivity to pain.
Arachidonic acid also leads to production of leukotrienes, via lipoxygenase enzyme ( Figure 1 ). Prostaglandins also have pathophysiologic effects such as erythema and increased local blood flow, hyperalgesia, probably due to sensitization of pain receptors, and increased body temperature at the hypothalamus through cytokine stimulation. When prostaglandin production is increased, there is increased sensitivity to pain and fever and increased inflammatory response. Nevertheless, prostaglandins are also capable of anti-inflammatory action due to suppression of IL-1 and TNF synthesis.
Mechanism of action
The mechanism of action of NSAIDs consists in suppression of COX enzymes, resulting in reduction of the production of prostaglandins, thus controlling inflammation, pain and fever.
There are some anti-inflammatories that selectively or specifically inhibit wither COX 1 or COX 2. 6 Only COX 1 inhibits thromboxane formation. COX 1 inhibition is associated with increased risk of gastrointestinal bleeding and damage. Selective and specific COX 2 inhibitors were developed in an attempt to reduce the incidence of adverse effects of COX 1 inhibition. 2 ‡ In clinical practice acetylsalicylic acid is used in children with inflammatory diseases of all ages, but it is not recommended in cases with suspected viral etiology because of the increased risk of Reye syndrome. § Indomethacin is used to treat persistent ductus arteriosus in newborns and to control of fever and pain in children and adolescents with juvenile idiopathic arthritis (systemic type) and arthritis related to enthesitis. || Parecoxib is metabolized into valdecoxib in less than 1 hour and is contraindicated in cases of sulfonamide allergy.
The NSAID dose necessary to reduce inflammation is larger than that needed to inhibit prostaglandin formation, suggesting that other mechanisms mediate the antiinflammatory effects. In addition to suppressing prostaglandin production, current anti-inflammatories inhibit specific proteases involved in breaking down proteoglycans and collagens in cartilage, and inhibit the generation of oxygen free radicals, particularly superoxide. 8 These medications also interfere with the liberation of bradykinin, with the lymphocyte response to antigen stimulus, with phagocytosis and with chemotaxis of granulocytes and monocytes. 8 
Pharmacokinetic
The following are characteristics of NSAIDs: rapid absorption; the majority of absorption takes place in the stomach and the upper portion of the small intestine; absorption is reduced when taken at night; the majority binds with plasma proteins; the pharmacological effect comes from the drug in its free state (unbound); metabolism is predominantly hepatic and is faster in children; excretion is renal; elimination is faster in children than in adults, requiring more frequent doses.
A study of 11 children with neoplasias assessed the pharmacokinetics of celecoxib. 9 The authors observed significant differences in terms of the availability of celecoxib in children compared with in adults, such as elimination that is twice as fast and a half-life that is half as long. They also observed that absorption of the medication is optimized when taken with a fat-rich meal.
In a study undertaken with 18 patients with juvenile rheumatoid arthritis, the pharmacokinetics of meloxicam suspension was evaluated, with greater elimination of the medication being observed in the younger children, although with a similar half-life to other age groups. 10 
Indications
The most common indications for NSAIDs in childhood and adolescence are control of fever, acute and chronic pains and inflammation. Acetylsalicylic acid, naproxen, ibuprofen and tolmetin are the only ones approved for pediatric use by the Food and Drug Administration (FDA).
Despite not being licensed for the pediatric age group, indomethacin is used to control fever and pain in children and adolescents with juvenile idiopathic arthritis (JIA).
Selective COX 2 inhibitors are indicated for patients who exhibit adverse effects that are confirmed to be related to nonselective NSAID use, such as gastric intolerance that cannot be controlled by combination with gastroprotective medication. In the pediatric age group, the use of COX 2 is limited since a majority of these medicines are contraindicated before 18 years of age. NSAIDs. 21 
Adverse effects
There is no overwhelming evidence that demonstrates the superiority of one NSAID over another in terms of effectiveness and, very often, the choice is based on lower frequency and intensity of side effects and on the cost of the medication. Another major concern is the growing number of children and adolescents observed during recent years with hypertension and/or obesity as a result of inadequate diet and of inactivity. In a randomized double-blind study of 225 children with juvenile idiopathic arthritis, the authors evaluated the efficacy and safety of two doses of meloxicam compared with naproxen, observing at least one adverse effect in 74% of the patients who were given 0.125 mg/kg/day of meloxicam, 80% in the group who were given 0.25 mg/kg/day of meloxicam and 85% in the naproxen group. 14 Gastrointestinal disorders such as pain, diarrhea, nausea and vomiting were the most frequent complaints, (Table 3) .
Drug interactions
Nonsteroidal anti-inflammatories bind strongly to plasma proteins and as a result they may displace other medications from their binding sites, which can occurs with methotrexate, phenytoin and sulfonylureas, increasing their activity and toxicity.
Summing up, in general NSAIDs should only be used when there is a precise indication, since they can cause adverse effects even when used for short periods. Selective Long-term randomized controlled studies are needed, especially in order to confirm safety.
